Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for TCI Co., Ltd. (8436:TWSE), powered by AI.
TCI Co., Ltd. is currently trading at $117.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for TCI Co., Ltd. on Alpha Lenz.
View TCI Co., Ltd.'s valuation metrics on Alpha Lenz.
“TCI Co., Ltd.'s ROE is 12.0%. Explore profitability and growth together.”
Ask for details →TCI Co., Ltd. is a biotechnology and health technology company specializing in the research, development, and manufacturing of functional foods, dietary supplements, and skincare products. Founded in 1980 and headquartered in Taipei, TCI operates globally across Asia, North America, and Europe, serving as a contract development and manufacturing organization (CDMO). The company offers a diverse portfolio that includes functional beverages, double-layered tablets, capsules, microencapsulated beads, probiotics, and various types of cosmetics such as creams, bio-cellulose masks, and serums. Combining advanced R&D capabilities with automated production and rigorous quality control, TCI tailors custom formulations for private label clients and brand owners, meeting regulatory and market-entry needs. The firm emphasizes AI-driven innovation and sustainability, contributing to both consumer health and broader environmental and social goals. TCI’s operations support clients ranging from emerging brands to established companies, making it an influential supplier in the health supplement and personal care markets, and reinforcing its role as a key partner in bringing functional, high-performance products to consumers worldwide.
“TCI Co., Ltd.'s ROE is 12.0%. Explore profitability and growth together.”
Ask for details →TCI Co., Ltd. (ticker: 8436) is a company listed on TWSE in the Consumer Defensive sector (Household & Personal Products).
The current price is 117 with a P/E ratio of -x and P/B of -x.
ROE is 12.03% and operating margin is 16.66%. Annual revenue is $7.0B.